Skip to content
OpenCapital
Get started

Harmony Biosciences Holdings, Inc. HRMY EBIT

EBIT at other companies

Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
-$53.42M-148%
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
$141.77M+41.3%
Acadia Pharmaceuticals logo
Acadia PharmaceuticalsACAD
-$4.62M-124%
Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
——
Alkermes logo
AlkermesALKS
——
Axsome Therapeutics logo
Axsome TherapeuticsAXSM
——

Other financials

Income statement

See full
Revenue$215.4M+16.6%
Gross profit$170.9M+11.9%
Operating income$37.3M-33.7%
Net income$32.5M-28.7%
EPS (diluted)$0.55-29.5%

Balance sheet

See full
Cash & equivalents$589.4M+20.5%
Total debt$164.6M-7.2%
Total equity$910.3M+26.3%
Total assets$1.3B+20.5%

Cash flow

See full
Operating cash flow$27.8M-18.3%
CapEx$107.0K-79.1%
Free cash flow$126.0M+67.9%

Valuation

See full
Market cap$1.98B-14.9%
Enterprise value$1.55B-24.9%
P/E13.6×-1.6×
P/S2.2×-0.9×

Profitability

See full
Gross margin76.5%-1.8pp
Operating margin21.1%-5.1pp
Net margin16.2%-4.3pp
FCF margin40.1%+9.5pp

Returns & leverage

See full
Return on equity17.9%-6.9pp
Debt / equity0.2×-0.1×
Current ratio3.6×-0.1×

Where this comes from

Calculated from Harmony Biosciences Holdings, Inc.’s reported figures.

$37.3Moperating income+$39.7Mincome before tax+$3.2Minterest expense=$37.29M

The official record: Harmony Biosciences Holdings, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Harmony Biosciences Holdings, Inc.'s ebit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Harmony Biosciences Holdings, Inc.'s EBIT?
Harmony Biosciences Holdings, Inc. (HRMY) reported EBIT of $37.29M in Q1 2026.
How has Harmony Biosciences Holdings, Inc.'s EBIT changed year-over-year?
Harmony Biosciences Holdings, Inc.'s EBIT decreased by 33.7% year-over-year, from $56.25M to $37.29M.
What is the long-term trend for Harmony Biosciences Holdings, Inc.'s EBIT?
Over 4 years (2021 to 2025), Harmony Biosciences Holdings, Inc.'s EBIT has grown at a 24.2% compound annual growth rate (CAGR), from $87.53M to $208.47M.
What does EBIT mean?
Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.